Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis
Hereditary Hemochromatosis and Telomere Length
A novel mutation in human IKBalpha identifies a domain essential for function
FIRST WORDS Project: Implementing Surveillance to Determine the Prevalence of ASD
Antidepressant Drugs in Treatment of Anxiety Disorders
Recently added grants:
Functional Heterogeneity of Hypocretin Neurons
L1CAM adhesion and signaling pathways in C. elegans
Sex differences in brain injury following pediatric cardiac arrest
Congenital Myasthenic Syndromes
Demyelination is coupled to neuronal hyperexcitability leading to seizures
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095129-002
Application #
6688608
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2003
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
NIH 2002
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
Comments
Be the first to comment on this grant